Review





Similar Products

primary antibodies against il6  (Servicebio Inc)
86
Servicebio Inc primary antibodies against il6
Primary Antibodies Against Il6, supplied by Servicebio Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+antibody+against+il6/pm41175706-95-0-12?v=Servicebio+Inc
Average 86 stars, based on 1 article reviews
primary antibodies against il6 - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier
primary antibodies against il6  (Cell Signaling Technology Inc)
96
Cell Signaling Technology Inc primary antibodies against il6
Primary Antibodies Against Il6, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+antibody+against+il6/pm40596558-49-0-45?v=Cell+Signaling+Technology+Inc
Average 96 stars, based on 1 article reviews
primary antibodies against il6 - by Bioz Stars, 2026-07
96/100 stars
  Buy from Supplier
primary antibodies against il6  (Huabio Inc)
86
Huabio Inc primary antibodies against il6
Primary Antibodies Against Il6, supplied by Huabio Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+antibody+against+il6/pmc12722482-50-0-3?v=Huabio+Inc
Average 86 stars, based on 1 article reviews
primary antibodies against il6 - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier
primary rabbit antibodies against foxo3a, il6, phospho-akt, akt, phospho-erk, erk, phospho-nfκb and nfκb  (Cell Signaling Technology Inc)
90
Cell Signaling Technology Inc primary rabbit antibodies against foxo3a, il6, phospho-akt, akt, phospho-erk, erk, phospho-nfκb and nfκb
Primary Rabbit Antibodies Against Foxo3a, Il6, Phospho Akt, Akt, Phospho Erk, Erk, Phospho Nfκb And Nfκb, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+antibody+against+il6/pm39824385-66-41-42?v=Cell+Signaling+Technology+Inc
Average 90 stars, based on 1 article reviews
primary rabbit antibodies against foxo3a, il6, phospho-akt, akt, phospho-erk, erk, phospho-nfκb and nfκb - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
primary antibodies against il6, tnfα, il-1β, il-17, rorγt, foxp3, and il-10  (Servicebio Inc)
90
Servicebio Inc primary antibodies against il6, tnfα, il-1β, il-17, rorγt, foxp3, and il-10
Primary Antibodies Against Il6, Tnfα, Il 1β, Il 17, Rorγt, Foxp3, And Il 10, supplied by Servicebio Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+antibody+against+il6/pmc11096707-54-20-21?v=Servicebio+Inc
Average 90 stars, based on 1 article reviews
primary antibodies against il6, tnfα, il-1β, il-17, rorγt, foxp3, and il-10 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
primary antibodies against il6  (Affinity Biosciences)
90
Affinity Biosciences primary antibodies against il6
Primary Antibodies Against Il6, supplied by Affinity Biosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+antibody+against+il6/pm37038162-80-4-11?v=Affinity+Biosciences
Average 90 stars, based on 1 article reviews
primary antibodies against il6 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
rat monoclonal primary antibodies against il 6  (OriGene)
92
OriGene rat monoclonal primary antibodies against il 6
Lithium suppresses activation of inflammatory cytokines in the spinal cord of rats with SCI . Sham group: No spinal cord injury or treatment; SCI group: spinal cord injury only; LiCl group: lithium treatment after spinal cord injury. (A–C) TNF-α (A), IL-1β (B), and <t>IL-6</t> (C) expression in the spinal cord were detected by enzyme-linked immunosorbent assay. (D) Representative immunohistochemical staining for IL-1β 7 days after surgery. The number of IL-1β-positive cells was higher in the LiCl group than in the sham group, but lower than in the SCI group. Black arrows indicate IL-1β-positive cells. Scale bars: 50 μm. (E) Quantification of IL-1β-positive cells 7 days after surgery. (F, G) TNF-α, IL-1β, and IL-6 expression. Data are shown as mean ± SD ( n = 6). * P < 0.05, vs . sham group; # P < 0.05, vs . SCI group (one-way analysis of variance followed by the least significant difference test). IL-1β: Interleukin-1β; IL-6: <t>interleukin-6;</t> LiCl: lithium chloride; SCI: spinal cord injury; TNF-α: tumor necrosis factor-alpha.
Rat Monoclonal Primary Antibodies Against Il 6, supplied by OriGene, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+antibody+against+il6/pmc08643056-113-9-16?v=OriGene
Average 92 stars, based on 1 article reviews
rat monoclonal primary antibodies against il 6 - by Bioz Stars, 2026-07
92/100 stars
  Buy from Supplier
primary antibodies against phosphojnk, jnk, iκbα, p65, lamin, il6  (Cell Signaling Technology Inc)
90
Cell Signaling Technology Inc primary antibodies against phosphojnk, jnk, iκbα, p65, lamin, il6
Lithium suppresses activation of inflammatory cytokines in the spinal cord of rats with SCI . Sham group: No spinal cord injury or treatment; SCI group: spinal cord injury only; LiCl group: lithium treatment after spinal cord injury. (A–C) TNF-α (A), IL-1β (B), and <t>IL-6</t> (C) expression in the spinal cord were detected by enzyme-linked immunosorbent assay. (D) Representative immunohistochemical staining for IL-1β 7 days after surgery. The number of IL-1β-positive cells was higher in the LiCl group than in the sham group, but lower than in the SCI group. Black arrows indicate IL-1β-positive cells. Scale bars: 50 μm. (E) Quantification of IL-1β-positive cells 7 days after surgery. (F, G) TNF-α, IL-1β, and IL-6 expression. Data are shown as mean ± SD ( n = 6). * P < 0.05, vs . sham group; # P < 0.05, vs . SCI group (one-way analysis of variance followed by the least significant difference test). IL-1β: Interleukin-1β; IL-6: <t>interleukin-6;</t> LiCl: lithium chloride; SCI: spinal cord injury; TNF-α: tumor necrosis factor-alpha.
Primary Antibodies Against Phosphojnk, Jnk, Iκbα, P65, Lamin, Il6, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+antibody+against+il6/pm33541845-72-31-32?v=Cell+Signaling+Technology+Inc
Average 90 stars, based on 1 article reviews
primary antibodies against phosphojnk, jnk, iκbα, p65, lamin, il6 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

Image Search Results


Lithium suppresses activation of inflammatory cytokines in the spinal cord of rats with SCI . Sham group: No spinal cord injury or treatment; SCI group: spinal cord injury only; LiCl group: lithium treatment after spinal cord injury. (A–C) TNF-α (A), IL-1β (B), and IL-6 (C) expression in the spinal cord were detected by enzyme-linked immunosorbent assay. (D) Representative immunohistochemical staining for IL-1β 7 days after surgery. The number of IL-1β-positive cells was higher in the LiCl group than in the sham group, but lower than in the SCI group. Black arrows indicate IL-1β-positive cells. Scale bars: 50 μm. (E) Quantification of IL-1β-positive cells 7 days after surgery. (F, G) TNF-α, IL-1β, and IL-6 expression. Data are shown as mean ± SD ( n = 6). * P < 0.05, vs . sham group; # P < 0.05, vs . SCI group (one-way analysis of variance followed by the least significant difference test). IL-1β: Interleukin-1β; IL-6: interleukin-6; LiCl: lithium chloride; SCI: spinal cord injury; TNF-α: tumor necrosis factor-alpha.

Journal: Neural Regeneration Research

Article Title: Lithium promotes recovery after spinal cord injury

doi: 10.4103/1673-5374.327348

Figure Lengend Snippet: Lithium suppresses activation of inflammatory cytokines in the spinal cord of rats with SCI . Sham group: No spinal cord injury or treatment; SCI group: spinal cord injury only; LiCl group: lithium treatment after spinal cord injury. (A–C) TNF-α (A), IL-1β (B), and IL-6 (C) expression in the spinal cord were detected by enzyme-linked immunosorbent assay. (D) Representative immunohistochemical staining for IL-1β 7 days after surgery. The number of IL-1β-positive cells was higher in the LiCl group than in the sham group, but lower than in the SCI group. Black arrows indicate IL-1β-positive cells. Scale bars: 50 μm. (E) Quantification of IL-1β-positive cells 7 days after surgery. (F, G) TNF-α, IL-1β, and IL-6 expression. Data are shown as mean ± SD ( n = 6). * P < 0.05, vs . sham group; # P < 0.05, vs . SCI group (one-way analysis of variance followed by the least significant difference test). IL-1β: Interleukin-1β; IL-6: interleukin-6; LiCl: lithium chloride; SCI: spinal cord injury; TNF-α: tumor necrosis factor-alpha.

Article Snippet: Subsequently, the membranes were incubated overnight at 4°C with rat monoclonal primary antibodies against IL-6 (1:1000, Acris Antibodies GmbH, Herford, Germany; Cat# SM1695PX, RRID:AB_1004115), IL-1β (1:100, Miltenyi Biotec, Bergisch Gladbach, Germany; Cat# 130-125-220, RRID:AB_2889697), TNF-α (1:100, Miltenyi Biotec; Cat# 130-102-386, RRID:AB_2661141), NLRP3 (1:1000, MyBioSource, San Diego, CA, USA; Cat# MBS604215, RRID:AB_10911109), ASC (1:2000, Gabriel Núñez, University of Michigan, Ann Arbor, MI, USA; Cat# GN-ASC, RRID:AB_2750645), pro-Caspase-1 (1:1000, ProSci, San Diego, CA, USA; Cat# 48-495, RRID:AB_1945485), Caspase-1 (1:1000, Acris Antibodies GmbH; Cat# AP06610PU-N, RRID:AB_1611115), GSDMD (1:100, Thermo Fisher Scientific; Cat# A305-736A-M, RRID:AB_2782894), and IL-18 (1:100, DSHB, Iowa City, IA, USA; Cat# CPTC-IL18-2, RRID:AB_1553716), followed by incubation with horseradish peroxidase-conjugated rabbit anti-rat IgG (1:1000, Biorbyt, Cat# orb21564, RRID:AB_10932535) at 20°C for 1 hour, and finally stained with a diaminobenzidine solution.

Techniques: Activation Assay, Expressing, Enzyme-linked Immunosorbent Assay, Immunohistochemical staining, Staining

Lithium attenuates inflammatory, oxidative, and pyroptotic injury in PC12 cells subjected to OGD . Con group: untreated PC12 cells; OGD group: PC12 cells subjected to OGD; OGD + LiCl group: PC12 cells subjected to OGD and treated with LiCl; OGD + LiCl + ATRA group: PC12 cells subjected to OGD and treated with LiCl and the Nrf2 inhibitor ATRA. (A–I) TNF-α (A), IL-1β (B), IL-6 (C), CAT (D), GSH-Px (E), LDH (F), SOD (G), MDA (H), and T-AOC (I) expression as detected by ELISA. (J–N) Flow cytometry analysis of the percentage of pyroptotic PC12 cells. Data are shown as mean ± SD ( n = 6). * P < 0.05, vs . control group; # P < 0.05, vs . OGD group; & P < 0.05, vs . OGD + LiCl group (one-way analysis of variance followed by least significant difference test). ATRA: All-trans retinoic acid; CAT: catalase; Con: control; GSH-Px: glutathione peroxidase; IL-1β: interleukin-1β; IL-6: interleukin-6; LiCl: lithium chloride; LPO: lipid peroxide; MDA: malondialdehyde; OGD: oxygen glucose deprivation; SOD: superoxide dismutase; T-AOC: total antioxidant capacity; TNF-α: tumor necrosis factor-alpha.

Journal: Neural Regeneration Research

Article Title: Lithium promotes recovery after spinal cord injury

doi: 10.4103/1673-5374.327348

Figure Lengend Snippet: Lithium attenuates inflammatory, oxidative, and pyroptotic injury in PC12 cells subjected to OGD . Con group: untreated PC12 cells; OGD group: PC12 cells subjected to OGD; OGD + LiCl group: PC12 cells subjected to OGD and treated with LiCl; OGD + LiCl + ATRA group: PC12 cells subjected to OGD and treated with LiCl and the Nrf2 inhibitor ATRA. (A–I) TNF-α (A), IL-1β (B), IL-6 (C), CAT (D), GSH-Px (E), LDH (F), SOD (G), MDA (H), and T-AOC (I) expression as detected by ELISA. (J–N) Flow cytometry analysis of the percentage of pyroptotic PC12 cells. Data are shown as mean ± SD ( n = 6). * P < 0.05, vs . control group; # P < 0.05, vs . OGD group; & P < 0.05, vs . OGD + LiCl group (one-way analysis of variance followed by least significant difference test). ATRA: All-trans retinoic acid; CAT: catalase; Con: control; GSH-Px: glutathione peroxidase; IL-1β: interleukin-1β; IL-6: interleukin-6; LiCl: lithium chloride; LPO: lipid peroxide; MDA: malondialdehyde; OGD: oxygen glucose deprivation; SOD: superoxide dismutase; T-AOC: total antioxidant capacity; TNF-α: tumor necrosis factor-alpha.

Article Snippet: Subsequently, the membranes were incubated overnight at 4°C with rat monoclonal primary antibodies against IL-6 (1:1000, Acris Antibodies GmbH, Herford, Germany; Cat# SM1695PX, RRID:AB_1004115), IL-1β (1:100, Miltenyi Biotec, Bergisch Gladbach, Germany; Cat# 130-125-220, RRID:AB_2889697), TNF-α (1:100, Miltenyi Biotec; Cat# 130-102-386, RRID:AB_2661141), NLRP3 (1:1000, MyBioSource, San Diego, CA, USA; Cat# MBS604215, RRID:AB_10911109), ASC (1:2000, Gabriel Núñez, University of Michigan, Ann Arbor, MI, USA; Cat# GN-ASC, RRID:AB_2750645), pro-Caspase-1 (1:1000, ProSci, San Diego, CA, USA; Cat# 48-495, RRID:AB_1945485), Caspase-1 (1:1000, Acris Antibodies GmbH; Cat# AP06610PU-N, RRID:AB_1611115), GSDMD (1:100, Thermo Fisher Scientific; Cat# A305-736A-M, RRID:AB_2782894), and IL-18 (1:100, DSHB, Iowa City, IA, USA; Cat# CPTC-IL18-2, RRID:AB_1553716), followed by incubation with horseradish peroxidase-conjugated rabbit anti-rat IgG (1:1000, Biorbyt, Cat# orb21564, RRID:AB_10932535) at 20°C for 1 hour, and finally stained with a diaminobenzidine solution.

Techniques: Expressing, Enzyme-linked Immunosorbent Assay, Flow Cytometry